| Hans-Günter Meyer-Thompson | Naloxon
Pharmacokinetics of a novel, approved, 1.4 mg intranasal naloxone formulation for reversal of opioid overdose - a randomised controlled trial.
Pharmacokinetics of a novel, approved, 1.4 mg intranasal naloxone formulation for reversal of opioid overdose - a randomised controlled trial.
Skulberg AK, Åsberg A, Khiabani HZ, Røstad H, Tylleskar I, Dale O.
Addiction. 2019 Jan 14. doi: 10.1111/add.14552.
Abstract